Yaohui Jiang

Nov 20, 2024 | nutritionandmetabolism.biomedcentral.com | Xiaojie Chen |Yifan Zhao |Jihong Sun |Yaohui Jiang |Yi Tang

Table 1 displayed the basic characteristics of all individuals in the study, while Table 2 showcased similar data sorted by sex. A total of 11,687 suitable individuals took part in this research (5,964 females and 5,723 males), with a median age of 49.74 years. As per diagnostic standards, 2,542 (42.62%) females and 2,350(41.06%)males were diagnosed with MetS.

May 25, 2023 | pubmed.ncbi.nlm.nih.gov | Yaohui Jiang |Jun Xie

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Apr 14, 2023 | frontiersin.org | Yaohui Jiang

Keywords: empagliflozin, heart failure with preserved ejection fraction, cost-effectiveness analysis, China, pharmaco economic Citation: Jiang Y and Xie J (2023) Corrigendum: Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China. Front. Cardiovasc. Med. 10:1205721. doi: 10.3389/fcvm.2023.1205721 Received: 14 April 2023; Accepted: 24 April 2023;Published: 9 May 2023.